Future Prospects of the Lung Cancer Genomic Testing Market 2035
Navigating Market Hurdles and Emerging Trends in Precision Oncology While genomic characterization has redefined lung cancer care, several operational and systemic challenges continue to hinder widespread adoption. High testing costs and complex reimbursement frameworks remain major hurdles, particularly in low- and middle-income regions. Comprehensive Next-Generation Sequencing (NGS) assays...
0 Commentaires 0 Parts 102 Vue 0 Aperçu